Non-small cell cancer (NSCLC) tumor markers are signs of specific types of tumors. Doctors look for these markers to aid in the diagnosis and treatment of lung cancer. Doctors use several tests to ...

Using preoperative chest CT scans, researchers identified novel preoperative biomarkers for lung cancer recurrence ...

An investigational therapy significantly shrank lung cancer tumors that are notoriously resistant to treatment by encouraging an attack from natural killer (NK) cells in an animal model ...

A father from Seattle, Washington was shocked and overwhelmed after strangers came together to raise more than $150k for him ...

Findings were similar for lung cancer-specific survival ... randomized trial showed that sublobar resection performed as well as lobectomy for NSCLC tumors ≤2 cm. Around the same time, the ...

are associated with improved long-term survival compared to wedge resection for patients with early-stage non-small cell lung cancer (NSCLC). The study analyzed outcomes for more than 32,000 stage ...

Blood clots form in response to signals from the lungs of cancer patients—not from other organ sites, as previously thought—according to a preclinical study by Weill Cornell Medicine, Memorial Sloan ...

received a positive recommendation from NICE for NHS use as an adjuvant treatment option after complete tumor resection in adult patients with stage IB-IIIA non-small cell lung cancer (NSCLC ...

Opdualag is a fixed-dose combination of nivolumab, a programmed death receptor-1 blocking antibody, and relatlimab, a lymphocyte activation gene 3 blocking antibody.